4.2 Article

Clinical Management of a Pandrug-Resistant OXA-48 Klebsiella pneumoniae Infection in the Pediatric Intensive Care Unit

Related references

Note: Only part of the references are listed.
Review Infectious Diseases

Ceftazidime-Avibactam for the Treatment of Serious Gram-Negative Infections with Limited Treatment Options: A Systematic Literature Review

Alex Soriano et al.

Summary: This systematic literature review evaluated the real-world use of ceftazidime-avibactam for infections caused by aerobic Gram-negative organisms in adults with limited treatment options. Results showed successful outcomes and infrequent resistance emergence, making it a valuable treatment option for such infections.

INFECTIOUS DISEASES AND THERAPY (2021)

Review Microbiology

Carbapenemases in Enterobacteriaceae: Detection and Antimicrobial Therapy

Xiaoyan Cui et al.

FRONTIERS IN MICROBIOLOGY (2019)

Review Microbiology

Treatment of Infections by OXA-48-Producing Enterobacteriaceae

Adam Stewart et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)

Article Infectious Diseases

A prospective study of treatment of carbapenem-resistant Enterobacteriaceae infections and risk factors associated with outcome

Claudia M. D. de Maio Carrilho et al.

BMC INFECTIOUS DISEASES (2016)

Article Microbiology

Successful Treatment of Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae Bacteremia

Jose F. Camargo et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)

Article Infectious Diseases

Blood stream infections due to OXA-48-like carbapenemase-producing Enterobacteriaceae: treatment and survival

Ilker Inanc Balkan et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2014)

Article Infectious Diseases

Combination therapy for carbapenem-resistant Gram-negative bacteria

Mical Paul et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)

Article Immunology

Deaths Attributable to Carbapenem-Resistant Enterobacteriaceae Infections

Matthew E. Falagas et al.

EMERGING INFECTIOUS DISEASES (2014)

Article Biotechnology & Applied Microbiology

Risk Factors for the First Episode of Klebsiella pneumoniae Resistant to Carbapenems Infection in Critically Ill Patients: A Prospective Study

Konstantinos Mantzarlis et al.

BIOMED RESEARCH INTERNATIONAL (2013)

Article Infectious Diseases

Rapid emergence and spread of OXA-48-producing carbapenem-resistant Enterobacteriaceae isolates in Belgian hospitals

Youri Glupczynski et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)

Review Microbiology

Treatment of Klebsiella Pneumoniae Carbapenemase (KPC) infections: a review of published case series and case reports

Grace C. Lee et al.

ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2012)

Review Infectious Diseases

Clinically significant carbapenemases: an update

Timothy R. Walsh

CURRENT OPINION IN INFECTIOUS DISEASES (2008)

Article Microbiology

Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae

L Poirel et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)